Rashmi Nagaraj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rashmi Nagaraj has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Akila Prashant
Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, India
2 shared publications - Alagu Sankareswaran
Genomic Research on Complex Diseases Group (GRC-Group), CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), Hyderabad, India
2 shared publications Dimple Lavanuru
2 shared publications- Giriraj Ratan Chandak
CSIR-Centre for Cellular and Molecular Biology, Hyderabad, Telangana, India
2 shared publications - Nagendra Khadri
Department of Paediatrics, Mysore Medial College and Research Institute, Mysuru, India
2 shared publications - Navyashree Mugur Jagadeesha
Department of Biochemistry, JSS Medical College, JSS Academy of Higher Education & Research, Mysuru, India
2 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by Wolters Kluwer Health in Indian Journal of Medical Specialities
- Vol. 17 (3) , 189-194
Correlation of Modified Bronchiolitis Severity Score with Bronchiolitis Ultrasound Score in Pediatric Acute Bronchiolitis
Background and Objective: Acute bronchiolitis is the leading cause of lower respiratory tract infection and hospitalization in infants under 2 years of age. Clinical scoring systems like the modified bronchiolitis severity score (MBSS) used to assess disease severity are often subjective and may not fully reflect the extent of pulmonary involvement. Lung ultrasound (LUS) is a reliable, noninvasive diagnostic tool and bronchiolitis ultrasound score (BUS) was developed to standardize LUS assessment in bronchiolitis. This study aimed to assess the correlation between MBSS and BUS in children aged 1-month–2-years with features of acute bronchiolitis and evaluate the comparative diagnostic utility of LUS with chest X-ray (CXR). Materials and Methods: This cross-sectional observational study, done over a period of 24 months, included 35 children with features of acute bronchiolitis, who were assessed using MBSS, LUS, and CXR. LUS findings were scored using BUS criteria by trained personnel. Correlation between MBSS and BUS assessed using Pearson’s correlation and the sensitivity of LUS compared with that of CXR using McNemar`s test. Results: There was a statistically significant positive correlation between MBSS and BUS ( r = 0.65; P < 0.001) higher clinical severity scores were associated with increasing sonographic abnormalities. LUS had a sensitivity of 55% and specificity of 100% for detecting bronchiolitis, compared to 34.2% sensitivity with CXR. McNemar’s test ( P = 0.02) confirmed that LUS identified significantly more true cases than CXR. Conclusion: Significant positive correlation between MBSS and BUS supports the use of BUS as a reliable indicator of disease severity in children with acute bronchiolitis. LUS offered superior diagnostic yield and clinical correlation when compared to CXR.
- 6 July 2026
- Published by Wolters Kluwer Health in Indian Journal of Medical Specialities
- Vol. 17 (3) , 189-194
Open AccessCorrelation of Modified Bronchiolitis Severity Score with Bronchiolitis Ultrasound Score in Pediatric Acute Bronchiolitis
Background and Objective: Acute bronchiolitis is the leading cause of lower respiratory tract infection and hospitalization in infants under 2 years of age. Clinical scoring systems like the modified bronchiolitis severity score (MBSS) used to assess disease severity are often subjective and may not fully reflect the extent of pulmonary involvement. Lung ultrasound (LUS) is a reliable, noninvasive diagnostic tool and bronchiolitis ultrasound score (BUS) was developed to standardize LUS assessment in bronchiolitis. This study aimed to assess the correlation between MBSS and BUS in children aged 1-month–2-years with features of acute bronchiolitis and evaluate the comparative diagnostic utility of LUS with chest X-ray (CXR). Materials and Methods: This cross-sectional observational study, done over a period of 24 months, included 35 children with features of acute bronchiolitis, who were assessed using MBSS, LUS, and CXR. LUS findings were scored using BUS criteria by trained personnel. Correlation between MBSS and BUS assessed using Pearson’s correlation and the sensitivity of LUS compared with that of CXR using McNemar`s test. Results: There was a statistically significant positive correlation between MBSS and BUS ( r = 0.65; P < 0.001) higher clinical severity scores were associated with increasing sonographic abnormalities. LUS had a sensitivity of 55% and specificity of 100% for detecting bronchiolitis, compared to 34.2% sensitivity with CXR. McNemar’s test ( P = 0.02) confirmed that LUS identified significantly more true cases than CXR. Conclusion: Significant positive correlation between MBSS and BUS supports the use of BUS as a reliable indicator of disease severity in children with acute bronchiolitis. LUS offered superior diagnostic yield and clinical correlation when compared to CXR.
- Open Access
- 26 February 2026
- Published by Elsevier in SSRN Electronic Journal
Performance of a Type 1 Diabetes Genetic Risk Score in a Multi-Centric Study from India and its Implications in Clinical Practice
Background: Genetic risk scores (GRS) for type 1 diabetes (T1D) have been developed primarily in European populations, limiting their generalisability across ancestries. Indians differ from Europeans in clinical characteristics of T1D and overall genetic architecture, yet systematic evaluation of T1D GRS performance in multi-regional Indian cohorts is lacking.Methods: The study included 597 T1D patients and 3347 non-diabetic controls from different regions in India. Genotyping, imputation, quality control analysis, and construction of the 67-SNPs T1D GRS were performed using standardised pipelines. Discriminative performance was assessed using Receiver Operative Curve-Area under Curve (ROC-AUC) analysis, and optimal thresholds were derived using Youden’s index. HLA-DQ diplotype frequencies were compared, and association analysis was conducted using multivariable logistic regression.Findings: T1D GRS showed consistent discriminative performance across Indian cohorts [ROC-AUC=0.84 (range=0·78-0·87)], supporting its comprehensive use for T1D classification in India. Notably, its performance was lower in islet cell autoantibody (IA) negative compared with IA positive T1D patients (ROC-AUC, 0·75 vs 0·85) and in adult-onset than in childhood-onset patients (0·74 vs 0·84). We observed a lower frequency of protective HLA-DQ diplotypes and a strong association of HLA-DQ81 containing diplotypes in childhood-onset T1D. Application of an India-specific T1D GRS score improved the sensitivity than the European cut-off.Interpretation: T1D GRS is a valuable unified diagnostic tool in Indians, but its performance varies by islet cell autoantibody status and age at onset, likely reflecting population-specific HLA architecture. European-derived T1D GRS thresholds under-classify the genetic risk, highlighting the importance of ancestry-aware optimisation in Indians.
- 26 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessPerformance of a Type 1 Diabetes Genetic Risk Score in a Multi-Centric Study from India and its Implications in Clinical Practice
Background: Genetic risk scores (GRS) for type 1 diabetes (T1D) have been developed primarily in European populations, limiting their generalisability across ancestries. Indians differ from Europeans in clinical characteristics of T1D and overall genetic architecture, yet systematic evaluation of T1D GRS performance in multi-regional Indian cohorts is lacking.Methods: The study included 597 T1D patients and 3347 non-diabetic controls from different regions in India. Genotyping, imputation, quality control analysis, and construction of the 67-SNPs T1D GRS were performed using standardised pipelines. Discriminative performance was assessed using Receiver Operative Curve-Area under Curve (ROC-AUC) analysis, and optimal thresholds were derived using Youden’s index. HLA-DQ diplotype frequencies were compared, and association analysis was conducted using multivariable logistic regression.Findings: T1D GRS showed consistent discriminative performance across Indian cohorts [ROC-AUC=0.84 (range=0·78-0·87)], supporting its comprehensive use for T1D classification in India. Notably, its performance was lower in islet cell autoantibody (IA) negative compared with IA positive T1D patients (ROC-AUC, 0·75 vs 0·85) and in adult-onset than in childhood-onset patients (0·74 vs 0·84). We observed a lower frequency of protective HLA-DQ diplotypes and a strong association of HLA-DQ81 containing diplotypes in childhood-onset T1D. Application of an India-specific T1D GRS score improved the sensitivity than the European cut-off.Interpretation: T1D GRS is a valuable unified diagnostic tool in Indians, but its performance varies by islet cell autoantibody status and age at onset, likely reflecting population-specific HLA architecture. European-derived T1D GRS thresholds under-classify the genetic risk, highlighting the importance of ancestry-aware optimisation in Indians.
- Open Access
Performance of a Type 1 Diabetes Genetic Risk Score in a Multi-centric Study from India and its Implications in Clinical Practice
Summary: Background: Genetic risk scores (GRS) for type 1 diabetes (T1D) have been developed primarily in European populations, limiting their generalisability across ancestries. Indians differ from Europeans in clinical characteristics of T1D and overall genetic architecture, yet systematic evaluation of T1D GRS performance in multi-regional Indian cohorts is lacking. Methods: The study included 597 T1D patients and 3347 non-diabetic controls from different regions in India. Genotyping, imputation, quality control analysis, and construction of the 67-SNPs T1D GRS were performed using standardised pipelines. Discriminative performance was assessed using Receiver Operative Curve-Area under Curve (ROC-AUC) analysis, and optimal thresholds were derived using Youden’s index. HLA-DQ diplotype frequencies were compared, and association analysis was conducted using multivariable logistic regression. Findings: T1D GRS showed consistent discriminative performance across Indian cohorts [ROC-AUC=0.84 (range=0·78-0·87)], supporting its comprehensive use for T1D classification in India. Notably, its performance was lower in islet cell autoantibody (IA) negative compared with IA positive T1D patients (ROC-AUC, 0·75 vs 0·85) and in adult-onset than in childhood-onset patients (0·74 vs 0·84). We observed a lower frequency of protective HLA-DQ diplotypes and a strong association of HLA-DQ81 containing diplotypes in childhood-onset T1D. Application of an India-specific T1D GRS score improved the sensitivity than the European cut-off. Interpretation: T1D GRS is a valuable unified diagnostic tool in Indians, but its performance varies by islet cell autoantibody status and age at onset, likely reflecting population-specific HLA architecture. European-derived T1D GRS thresholds under-classify the genetic risk, highlighting the importance of ancestry-aware optimisation in Indians. Funding: CDRC grant CDRC202111026 and CSIR Intramural Grant P50. Research in context: Evidence before this study: Previous studies have shown that a 67-SNPs T1D genetic risk score (GRS) can distinguish T1D patients from non-diabetic controls and other forms of diabetes, but its performance varies across ancestries. Islet cell autoantibodies (IA) have important diagnostic value for classifying type 1 diabetes (T1D). However, their prevalence in India varies widely, with up to one-quarter of patients testing negative, limiting their clinical utility. Evidence supporting the use of the T1D GRS in India, combined with IA antibodies status is limited to a single cohort representing one linguistic group. The applicability of T1D GRS across multi-centric clinical settings has not been systematically evaluated. Added value of this study: This study validates the 67-SNPs T1D GRS across multiple Indian cohorts representing major linguistic groups, supporting its use as a unified diagnostic tool. Differences in T1DGRS performance between childhood-and adult-onset T1D are linked to enrichment of protective HLA-DQ diplotypes in adult-onset disease, providing genetic insight into disease heterogeneity. The study also demonstrates that European-derived GRS thresholds systematically under-classify genetic risk in Indians and the population-specific threshold is essential. Implications of all the available evidence: The European-derived T1D GRS can be applied across Indian clinical settings with consistent discriminative performance. However, its utility is influenced by islet cell autoantibody status and the age at onset of disease. Ancestry-aware threshold optimisation substantially improves diagnostic accuracy and is essential for equitable implementation of T1D GRS in Indians. Larger studies are needed to identify population-specific risk variants and further refine genetic tools for clinical diagnosis.
Open AccessPerformance of a Type 1 Diabetes Genetic Risk Score in a Multi-centric Study from India and its Implications in Clinical Practice
Summary: Background: Genetic risk scores (GRS) for type 1 diabetes (T1D) have been developed primarily in European populations, limiting their generalisability across ancestries. Indians differ from Europeans in clinical characteristics of T1D and overall genetic architecture, yet systematic evaluation of T1D GRS performance in multi-regional Indian cohorts is lacking. Methods: The study included 597 T1D patients and 3347 non-diabetic controls from different regions in India. Genotyping, imputation, quality control analysis, and construction of the 67-SNPs T1D GRS were performed using standardised pipelines. Discriminative performance was assessed using Receiver Operative Curve-Area under Curve (ROC-AUC) analysis, and optimal thresholds were derived using Youden’s index. HLA-DQ diplotype frequencies were compared, and association analysis was conducted using multivariable logistic regression. Findings: T1D GRS showed consistent discriminative performance across Indian cohorts [ROC-AUC=0.84 (range=0·78-0·87)], supporting its comprehensive use for T1D classification in India. Notably, its performance was lower in islet cell autoantibody (IA) negative compared with IA positive T1D patients (ROC-AUC, 0·75 vs 0·85) and in adult-onset than in childhood-onset patients (0·74 vs 0·84). We observed a lower frequency of protective HLA-DQ diplotypes and a strong association of HLA-DQ81 containing diplotypes in childhood-onset T1D. Application of an India-specific T1D GRS score improved the sensitivity than the European cut-off. Interpretation: T1D GRS is a valuable unified diagnostic tool in Indians, but its performance varies by islet cell autoantibody status and age at onset, likely reflecting population-specific HLA architecture. European-derived T1D GRS thresholds under-classify the genetic risk, highlighting the importance of ancestry-aware optimisation in Indians. Funding: CDRC grant CDRC202111026 and CSIR Intramural Grant P50. Research in context: Evidence before this study: Previous studies have shown that a 67-SNPs T1D genetic risk score (GRS) can distinguish T1D patients from non-diabetic controls and other forms of diabetes, but its performance varies across ancestries. Islet cell autoantibodies (IA) have important diagnostic value for classifying type 1 diabetes (T1D). However, their prevalence in India varies widely, with up to one-quarter of patients testing negative, limiting their clinical utility. Evidence supporting the use of the T1D GRS in India, combined with IA antibodies status is limited to a single cohort representing one linguistic group. The applicability of T1D GRS across multi-centric clinical settings has not been systematically evaluated. Added value of this study: This study validates the 67-SNPs T1D GRS across multiple Indian cohorts representing major linguistic groups, supporting its use as a unified diagnostic tool. Differences in T1DGRS performance between childhood-and adult-onset T1D are linked to enrichment of protective HLA-DQ diplotypes in adult-onset disease, providing genetic insight into disease heterogeneity. The study also demonstrates that European-derived GRS thresholds systematically under-classify genetic risk in Indians and the population-specific threshold is essential. Implications of all the available evidence: The European-derived T1D GRS can be applied across Indian clinical settings with consistent discriminative performance. However, its utility is influenced by islet cell autoantibody status and the age at onset of disease. Ancestry-aware threshold optimisation substantially improves diagnostic accuracy and is essential for equitable implementation of T1D GRS in Indians. Larger studies are needed to identify population-specific risk variants and further refine genetic tools for clinical diagnosis.
- Open Access
- 5 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 53 (3) , 212-217
Pancreatitis in children: Experience in a tertiary care medical college hospital
Background: Acute, acute recurrent and chronic pancreatitis cause significant health problems in the paediatric population. In view of the small number of patients, it is difficult to evaluate outcomes, genetic causes, treatments, prognostic indicators, severity, and epidemiologic factors in childhood in a prospective way. Objectives: To determine the characteristics of patients with pancreatitis (acute, chronic and recurrent) presenting to us. Method: This was a retrospective descriptive study of consecutive paediatric patients admitted between January 2017 and December 2020 (4 years) in our paediatric department with a diagnosis of pancreatitis. Patient characteristics, laboratory and imaging results, identified aetiology of pancreatitis, and recurrence rates were recorded and evaluated.Results: There were 34 visits, of which 28 were for acute pancreatitis (including 3 with acute on chronic pancreatitis), and 6 for an episode of recurrent pancreatitis. The median age for all visits was 9 years (range 2-16). Of the acute cases, 14 had uncertain or undetermined aetiologies, 3 had systemic diseases, 2 were associated with medications, most common being valproic acid, 3 were cholelithiasis-related, 5 were due to other infections and one was due to trauma; one child with 3 recurrent episodes was suspected to have a genetic basis and 1 child was diagnosed to have Rapunzel syndrome (trichobezoar). There were five patients with chronic pancreatitis, of which 3 had acute on chronic pancreatitis.Conclusions: Abdominal pain, nausea, vomiting, fever and jaundice were the common clinical presentations of acute pancreatitis in children. The common aetiological factors identified were infections (18%), systemic illness (11%), drug induced (7%) and obstructive/ cholelithiasis (7%); in 46% the aetiology was unknown.
- 5 September 2024
- Published by Sri Lanka Journals Online in Sri Lanka Journal of Child Health
- Vol. 53 (3) , 212-217
Open AccessPancreatitis in children: Experience in a tertiary care medical college hospital
Background: Acute, acute recurrent and chronic pancreatitis cause significant health problems in the paediatric population. In view of the small number of patients, it is difficult to evaluate outcomes, genetic causes, treatments, prognostic indicators, severity, and epidemiologic factors in childhood in a prospective way. Objectives: To determine the characteristics of patients with pancreatitis (acute, chronic and recurrent) presenting to us. Method: This was a retrospective descriptive study of consecutive paediatric patients admitted between January 2017 and December 2020 (4 years) in our paediatric department with a diagnosis of pancreatitis. Patient characteristics, laboratory and imaging results, identified aetiology of pancreatitis, and recurrence rates were recorded and evaluated.Results: There were 34 visits, of which 28 were for acute pancreatitis (including 3 with acute on chronic pancreatitis), and 6 for an episode of recurrent pancreatitis. The median age for all visits was 9 years (range 2-16). Of the acute cases, 14 had uncertain or undetermined aetiologies, 3 had systemic diseases, 2 were associated with medications, most common being valproic acid, 3 were cholelithiasis-related, 5 were due to other infections and one was due to trauma; one child with 3 recurrent episodes was suspected to have a genetic basis and 1 child was diagnosed to have Rapunzel syndrome (trichobezoar). There were five patients with chronic pancreatitis, of which 3 had acute on chronic pancreatitis.Conclusions: Abdominal pain, nausea, vomiting, fever and jaundice were the common clinical presentations of acute pancreatitis in children. The common aetiological factors identified were infections (18%), systemic illness (11%), drug induced (7%) and obstructive/ cholelithiasis (7%); in 46% the aetiology was unknown.
- 1 October 2022
- Published by Medknow in Journal of the Anatomical Society of India
- Vol. 71 (4) , 321-323
Milder and Later Presentation of Trisomy 13
Patau syndrome or Trisomy 13 is the least common and most severe of the viable autosomal trisomies. The frequent clinical features include holoprosencephaly, polydactyly, flexion of the fingers, rocker-bottom feet, cleft lip and palate, neural tube defects, and heart defects, with neurological involvement being the most consistent one. It is usually recognized at birth by the typical birth defects with poor neurologic performance. About 85%[FIGURE DASH]90% of cases die during infancy, with only 5% to 10% of patients alive beyond 1 year. Patients surviving beyond 1 year have a severe developmental handicap. We present here an infant who came with a relatively milder form of Patau syndrome and was confirmed by karyotyping.
- 1 October 2022
- Published by Medknow in Journal of the Anatomical Society of India
- Vol. 71 (4) , 321-323
Milder and Later Presentation of Trisomy 13
Patau syndrome or Trisomy 13 is the least common and most severe of the viable autosomal trisomies. The frequent clinical features include holoprosencephaly, polydactyly, flexion of the fingers, rocker-bottom feet, cleft lip and palate, neural tube defects, and heart defects, with neurological involvement being the most consistent one. It is usually recognized at birth by the typical birth defects with poor neurologic performance. About 85%[FIGURE DASH]90% of cases die during infancy, with only 5% to 10% of patients alive beyond 1 year. Patients surviving beyond 1 year have a severe developmental handicap. We present here an infant who came with a relatively milder form of Patau syndrome and was confirmed by karyotyping.
- Open Access
- 3 September 2022
- Published by Mansa STM Publishers in Indian Journal of Case Reports
- p. 237-239
Hematochezia in a 6-year-old girl: An unusual cause
Anorectal disorders, anal fissures, and distal polyps are the most common causes of hematochezia in children. However, inflammatory bowel disease (IBD), even though quite rare in children, can present with an isolated per rectal bleeding. Early onset IBD is described in patients younger than 10 years of age; however, these are rare instances of even neonates presenting with IBD. Here, we report the case of a 6-year-old girl who presented with episodes of per rectal bleeding for several months with severe anemia and malnutrition and was also found to have an anteriorly displaced anus. She underwent colonoscopy which revealed features suggestive of ulcerative colitis which was eventually confirmed by biopsy. She was treated with corticosteroids and aminosalicylate, namely, Mesalamine. Later, the patient was treated with Azathioprine which resulted in the complete resolution of symptoms and improvement in nutritional status that was evident on regular follow-ups. IBD in children younger than 10 years of age is a rare entity and requires a strong suspicion for diagnosis.
- 3 September 2022
- Published by Mansa STM Publishers in Indian Journal of Case Reports
- p. 237-239
Open AccessHematochezia in a 6-year-old girl: An unusual cause
Anorectal disorders, anal fissures, and distal polyps are the most common causes of hematochezia in children. However, inflammatory bowel disease (IBD), even though quite rare in children, can present with an isolated per rectal bleeding. Early onset IBD is described in patients younger than 10 years of age; however, these are rare instances of even neonates presenting with IBD. Here, we report the case of a 6-year-old girl who presented with episodes of per rectal bleeding for several months with severe anemia and malnutrition and was also found to have an anteriorly displaced anus. She underwent colonoscopy which revealed features suggestive of ulcerative colitis which was eventually confirmed by biopsy. She was treated with corticosteroids and aminosalicylate, namely, Mesalamine. Later, the patient was treated with Azathioprine which resulted in the complete resolution of symptoms and improvement in nutritional status that was evident on regular follow-ups. IBD in children younger than 10 years of age is a rare entity and requires a strong suspicion for diagnosis.
- Open Access
- 1 December 2020
- Published by Annex Publishers, LLC in Journal of Paediatrics and Neonatal Disorders
- Vol. 5 (1) , 1-5
Bosma Syndrome “Mimic” in a Young Infant - Case Report and Literature Review
Bosma arrhinia microphthalmia syndrome is a rare entity of unknown etiology, characterized by abnormalities of the nose and eyes and hypogonadotropic hypogonadism.
- 1 December 2020
- Published by Annex Publishers, LLC in Journal of Paediatrics and Neonatal Disorders
- Vol. 5 (1) , 1-5
Open AccessBosma Syndrome “Mimic” in a Young Infant - Case Report and Literature Review
Bosma arrhinia microphthalmia syndrome is a rare entity of unknown etiology, characterized by abnormalities of the nose and eyes and hypogonadotropic hypogonadism.
- Open Access
- 21 February 2020
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 8 (3) , 879-883
“Does cost of care influence the glycemic control, psychosocial illness and quality of care among adolescents with type 1 diabetes?: A hospital based cross section study in Mysuru, Karnataka
- 21 February 2020
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 8 (3) , 879-883
Open Access“Does cost of care influence the glycemic control, psychosocial illness and quality of care among adolescents with type 1 diabetes?: A hospital based cross section study in Mysuru, Karnataka
- Open Access
- 28 February 2017
- Published by Siddharth Health Research and Social Welfare Society in Pediatric Review: International Journal of Pediatric Research
- Vol. 4 (2) , 149-154
3 days vs. 7 days course of intravenous antibiotics for probable neonatal sepsis
Introduction: Duration of appropriate antibiotic therapy for neonatal sepsis does not have evidence-based guidelines. The rationale and safety of these recommendations have never been scientifically evaluated. Such untested approaches could result in the unnecessary use of antibiotics leading to increased cost of care, unneeded intravenous cannulation, prolonged hospitalization, mother-infant separation, increased colonization by pathogenic organisms and emergence of drug resistant strains. So, our objective was to compare 3 days v/s. 7 days course of intravenous antibiotics for probable neonatal sepsis in order to determine the optimal length of antibiotic therapy so that infants with genuine infection would be adequately treated while those without infection would not be over-treated. Methods: Randomized controlled trial (computerized randomization) done in the Neonatal Intensive Care Unit in a Tertiary care Teaching Hospital, Mysuru. About 150 neonates who were admitted in NICU for probable sepsis (clinical signs of sepsis and positive septic screening), who were on antibiotic therapy, with sterile blood culture at 3rd day of admission were the participants. Neonates who fulfilled the inclusion criteria were randomly divided into two groups, i.e; those who received 3 days of antibiotics and those who received 7 day course of antibiotics. Successful therapeutic outcome was measured in terms of weight gain, no apparent signs of sepsis as ascertained by clinical examination & no re hospitalization for sepsis. Results: Among the 150 eligible neonates in the study, (75 each in Groups 1 and 2, which were comparable with regard to term/preterm population and also early and late onset neonatal sepsis), there was no statistically significant difference in the outcome between the two groups in terms of mean age at presentation, gestational age, mode of delivery, age of onset of sepsis at presentation and relapse rates. However, the duration of hospital stay in group 1 babies who received 3 days of antibiotics was significantly shorter than in group 2 babies who received 7 days of antibiotics. Conclusion: 3 day course of antibiotics is enough for culture sterile probable sepsis, in both term and preterm babies and also in both early and late onset neonatal sepsis.
- 28 February 2017
- Published by Siddharth Health Research and Social Welfare Society in Pediatric Review: International Journal of Pediatric Research
- Vol. 4 (2) , 149-154
Open Access3 days vs. 7 days course of intravenous antibiotics for probable neonatal sepsis
Introduction: Duration of appropriate antibiotic therapy for neonatal sepsis does not have evidence-based guidelines. The rationale and safety of these recommendations have never been scientifically evaluated. Such untested approaches could result in the unnecessary use of antibiotics leading to increased cost of care, unneeded intravenous cannulation, prolonged hospitalization, mother-infant separation, increased colonization by pathogenic organisms and emergence of drug resistant strains. So, our objective was to compare 3 days v/s. 7 days course of intravenous antibiotics for probable neonatal sepsis in order to determine the optimal length of antibiotic therapy so that infants with genuine infection would be adequately treated while those without infection would not be over-treated. Methods: Randomized controlled trial (computerized randomization) done in the Neonatal Intensive Care Unit in a Tertiary care Teaching Hospital, Mysuru. About 150 neonates who were admitted in NICU for probable sepsis (clinical signs of sepsis and positive septic screening), who were on antibiotic therapy, with sterile blood culture at 3rd day of admission were the participants. Neonates who fulfilled the inclusion criteria were randomly divided into two groups, i.e; those who received 3 days of antibiotics and those who received 7 day course of antibiotics. Successful therapeutic outcome was measured in terms of weight gain, no apparent signs of sepsis as ascertained by clinical examination & no re hospitalization for sepsis. Results: Among the 150 eligible neonates in the study, (75 each in Groups 1 and 2, which were comparable with regard to term/preterm population and also early and late onset neonatal sepsis), there was no statistically significant difference in the outcome between the two groups in terms of mean age at presentation, gestational age, mode of delivery, age of onset of sepsis at presentation and relapse rates. However, the duration of hospital stay in group 1 babies who received 3 days of antibiotics was significantly shorter than in group 2 babies who received 7 days of antibiotics. Conclusion: 3 day course of antibiotics is enough for culture sterile probable sepsis, in both term and preterm babies and also in both early and late onset neonatal sepsis.
- 19 March 2012
- Published by Medknow in Indian Journal of Medical Specialities
- Vol. 3 (1) , 82-86
Young female with fever, recurrent arthralgias and Raynaud’s phenomenon
- 19 March 2012
- Published by Medknow in Indian Journal of Medical Specialities
- Vol. 3 (1) , 82-86
Young female with fever, recurrent arthralgias and Raynaud’s phenomenon